Skip to main content
. Author manuscript; available in PMC: 2013 Jan 11.
Published in final edited form as: Diabetologia. 2012 Feb 15;55(5):1446–1457. doi: 10.1007/s00125-012-2477-5

Table 1.

Activity and Levels of aPKCs and aPKC-dependent Expression of Lipogenic, Proinflammatory and Gluconeogenic Enzymes in Uncultured Hepatocytes of Non-diabetic and Type 2 Diabetic Humans

Parameter Uncultured
Non-Diabetic
Uncultured
T2DM
P Values
aPKC Activity 1 ± 0.14 2.53 ± 0.23 <0.001
"PKC-ι mRNA 1 ± 0.23 3.54 ± 0.72 <0.01
"PKC-ι Protein 1 ± 0.36 2.41 ± 0.67 <0.05
SREBP-1c mRNA 1 ± 0.17 3.08 ± 0.70 <0.05
FAS mRNA 1 ± 0.26 3.85 ± 1.15 <0.05
ACC mRNA 1 ± 0.26 2.77 ± 0.61 <0.05
TNFα mRNA 1 ± 0.26 2.55 ± 0.59 <0.05
PEPCK mRNA 1 ± 0.23 2.87 ± 0.61 <0.05
G6Pase mRNA 1 ± 0.22 3.32 ± 0.89 <0.05
PKC-ζ mRNA 1 ± 0.20 0.80 ± 0.19 NS

Hepatocytes of 5 non-diabetic and 5 type 2 diabetic (T2DM) subjects were analyzed directly, i.e., without overnight culturing, and results for each patient were expressed relative to the mean value of all non-diabetic patients, set at unity. Values are mean ± SEM of 4–5 determinations. P values were determined ANOVA. NS, not significant

HHS Vulnerability Disclosure